Jenscare Scientific Co., Ltd. (JENSCARE-B) filed its Monthly Return for Equity Issuer for the period ended 31 March 2026, confirming there were no movements in either authorised or issued share capital during the month.

Authorised / Registered Share Capital • Total authorised share capital stood unchanged at RMB 417.17 million, comprising: – 310.31 million H-shares with a par value of RMB 1 each, all listed on the Hong Kong Stock Exchange. – 106.86 million unlisted ordinary shares (domestic and unlisted foreign shares) with a par value of RMB 1 each.

Issued Shares and Treasury Shares • Issued H-shares (excluding treasury shares): 310.31 million. • Treasury shares: none. • Issued unlisted shares: 106.86 million. • No share issuances, cancellations, conversions, options, warrants or other equity-linked instruments were recorded in March.

Public Float • The company confirmed compliance with the Main Board Rule 13.32D(1), maintaining at least the initial prescribed public-float threshold of 17.32 % of total issued H-shares.

Governance • The monthly return was submitted on 9 April 2026 by Joint Company Secretary Ms Li Yuanyuan, affirming all regulatory confirmations required by the Hong Kong Stock Exchange.

Implication The unchanged share metrics underscore capital stability, while confirmed adherence to the 17.32 % public-float requirement supports continued compliance with Hong Kong listing rules.